 Raul Torres
Concepts (276)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| B-Lymphocytes | 31 | 2023 | 766 | 4.490 |
Why?
| | Lysophospholipids | 5 | 2023 | 65 | 2.950 |
Why?
| | CD8-Positive T-Lymphocytes | 7 | 2023 | 687 | 2.780 |
Why?
| | Receptors, Antigen, B-Cell | 15 | 2023 | 107 | 2.170 |
Why?
| | Receptors, Lysophosphatidic Acid | 7 | 2023 | 29 | 2.040 |
Why?
| | Guanine Nucleotide Exchange Factors | 6 | 2013 | 55 | 1.640 |
Why?
| | Antibodies, Neutralizing | 4 | 2019 | 221 | 1.520 |
Why?
| | Antibody Formation | 11 | 2018 | 266 | 1.500 |
Why?
| | Peripheral Tolerance | 2 | 2022 | 14 | 1.380 |
Why?
| | AIDS Vaccines | 3 | 2019 | 41 | 1.340 |
Why?
| | Signal Transduction | 17 | 2023 | 4509 | 1.330 |
Why?
| | HIV Antibodies | 3 | 2019 | 49 | 1.150 |
Why?
| | Central Tolerance | 3 | 2022 | 8 | 1.100 |
Why?
| | Immunity, Humoral | 4 | 2017 | 112 | 1.060 |
Why?
| | Immune Tolerance | 7 | 2017 | 323 | 1.060 |
Why?
| | Adaptive Immunity | 3 | 2023 | 155 | 0.960 |
Why?
| | Proto-Oncogene Proteins | 4 | 2010 | 608 | 0.910 |
Why?
| | Immunoglobulin M | 5 | 2023 | 246 | 0.820 |
Why?
| | Immunological Synapses | 1 | 2022 | 18 | 0.800 |
Why?
| | Mice | 39 | 2023 | 14860 | 0.800 |
Why?
| | HIV-1 | 2 | 2017 | 768 | 0.780 |
Why?
| | HIV Infections | 4 | 2019 | 2469 | 0.740 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2023 | 1139 | 0.730 |
Why?
| | Tumor Escape | 1 | 2021 | 35 | 0.720 |
Why?
| | CTLA-4 Antigen | 1 | 2021 | 76 | 0.720 |
Why?
| | Animals | 48 | 2023 | 31694 | 0.710 |
Why?
| | T-Lymphocytes | 7 | 2019 | 1736 | 0.710 |
Why?
| | Immunity, Innate | 3 | 2023 | 720 | 0.700 |
Why?
| | Cell Differentiation | 12 | 2022 | 1700 | 0.690 |
Why?
| | Lymphocyte Activation | 7 | 2022 | 1037 | 0.680 |
Why?
| | Autoantibodies | 11 | 2022 | 1345 | 0.670 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2021 | 193 | 0.650 |
Why?
| | Spleen | 6 | 2019 | 487 | 0.640 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 2019 | 154 | 0.630 |
Why?
| | Autoimmunity | 7 | 2022 | 813 | 0.620 |
Why?
| | Neoplasms | 2 | 2022 | 2097 | 0.590 |
Why?
| | Neoplasm Proteins | 1 | 2021 | 384 | 0.590 |
Why?
| | Mice, Inbred C57BL | 17 | 2019 | 4689 | 0.590 |
Why?
| | B-Lymphocyte Subsets | 5 | 2018 | 68 | 0.580 |
Why?
| | Mice, Knockout | 13 | 2022 | 2565 | 0.540 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2019 | 615 | 0.500 |
Why?
| | Precursor Cells, B-Lymphoid | 3 | 2023 | 34 | 0.490 |
Why?
| | Receptors, Lysosphingolipid | 3 | 2010 | 12 | 0.490 |
Why?
| | Macrophages, Peritoneal | 2 | 2011 | 93 | 0.460 |
Why?
| | Fibronectins | 2 | 2011 | 108 | 0.460 |
Why?
| | Macrophages, Alveolar | 3 | 2013 | 347 | 0.450 |
Why?
| | Receptors, Thromboxane | 2 | 2013 | 4 | 0.420 |
Why?
| | Rho Guanine Nucleotide Exchange Factors | 6 | 2013 | 19 | 0.420 |
Why?
| | Antineoplastic Agents | 1 | 2023 | 1879 | 0.410 |
Why?
| | Silicone Oils | 3 | 2017 | 26 | 0.390 |
Why?
| | Lupus Erythematosus, Systemic | 3 | 2022 | 219 | 0.380 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2011 | 119 | 0.370 |
Why?
| | Integrins | 2 | 2007 | 79 | 0.350 |
Why?
| | Integrin alpha5beta1 | 1 | 2010 | 9 | 0.350 |
Why?
| | Self Tolerance | 1 | 2010 | 28 | 0.350 |
Why?
| | Proprotein Convertases | 1 | 2010 | 14 | 0.350 |
Why?
| | Humans | 27 | 2023 | 114623 | 0.340 |
Why?
| | Chemotaxis, Leukocyte | 1 | 2010 | 130 | 0.340 |
Why?
| | Serine Endopeptidases | 1 | 2010 | 102 | 0.330 |
Why?
| | Immunoglobulin G | 7 | 2018 | 770 | 0.330 |
Why?
| | Immunity | 1 | 2010 | 121 | 0.320 |
Why?
| | Matrix Metalloproteinases | 1 | 2010 | 89 | 0.320 |
Why?
| | Interleukin-6 | 2 | 2023 | 676 | 0.320 |
Why?
| | Mice, Transgenic | 8 | 2019 | 1947 | 0.320 |
Why?
| | Interferon-alpha | 1 | 2010 | 186 | 0.320 |
Why?
| | Antibodies | 3 | 2016 | 371 | 0.310 |
Why?
| | Dendritic Cells | 4 | 2018 | 435 | 0.310 |
Why?
| | Homeostasis | 2 | 2018 | 573 | 0.290 |
Why?
| | Melanoma | 1 | 2013 | 619 | 0.280 |
Why?
| | Inflammation | 3 | 2022 | 2477 | 0.280 |
Why?
| | Toll-Like Receptors | 1 | 2008 | 167 | 0.280 |
Why?
| | Bronchial Hyperreactivity | 1 | 2007 | 95 | 0.270 |
Why?
| | Th2 Cells | 1 | 2007 | 154 | 0.260 |
Why?
| | Immunoglobulin Isotypes | 2 | 2022 | 32 | 0.260 |
Why?
| | Cells, Cultured | 7 | 2019 | 3881 | 0.250 |
Why?
| | Carcinogenesis | 2 | 2019 | 177 | 0.250 |
Why?
| | HIV Envelope Protein gp120 | 2 | 2017 | 56 | 0.250 |
Why?
| | Bone Marrow Cells | 3 | 2022 | 267 | 0.250 |
Why?
| | Cell Movement | 2 | 2008 | 868 | 0.250 |
Why?
| | Adjuvants, Immunologic | 4 | 2017 | 206 | 0.240 |
Why?
| | Growth Hormone | 2 | 2016 | 103 | 0.240 |
Why?
| | Antigens | 3 | 2013 | 318 | 0.220 |
Why?
| | Autoantigens | 4 | 2019 | 396 | 0.220 |
Why?
| | Monitoring, Immunologic | 1 | 2023 | 23 | 0.220 |
Why?
| | Immunoglobulin D | 1 | 2022 | 27 | 0.210 |
Why?
| | Cytokines | 3 | 2023 | 1840 | 0.210 |
Why?
| | Antigens, Differentiation, T-Lymphocyte | 2 | 2014 | 84 | 0.210 |
Why?
| | Lectins, C-Type | 2 | 2014 | 61 | 0.200 |
Why?
| | Inositol 1,4,5-Trisphosphate Receptors | 1 | 2022 | 26 | 0.200 |
Why?
| | Mice, Inbred BALB C | 9 | 2019 | 1143 | 0.200 |
Why?
| | Pneumonia | 1 | 2007 | 567 | 0.190 |
Why?
| | Interferons | 1 | 2022 | 151 | 0.190 |
Why?
| | Recombinant Proteins | 2 | 2015 | 1230 | 0.190 |
Why?
| | Antibody Affinity | 2 | 2012 | 52 | 0.190 |
Why?
| | Cytoskeleton | 1 | 2022 | 176 | 0.180 |
Why?
| | Immunologic Memory | 2 | 2013 | 313 | 0.180 |
Why?
| | Flow Cytometry | 6 | 2022 | 1083 | 0.170 |
Why?
| | RNA, Viral | 1 | 2023 | 565 | 0.170 |
Why?
| | Cell Line, Tumor | 2 | 2019 | 2710 | 0.170 |
Why?
| | Antigens, CD | 2 | 2014 | 442 | 0.170 |
Why?
| | Lipids | 1 | 2023 | 580 | 0.170 |
Why?
| | Perforin | 1 | 2019 | 18 | 0.170 |
Why?
| | Class Ia Phosphatidylinositol 3-Kinase | 1 | 2019 | 7 | 0.160 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 2019 | 44 | 0.160 |
Why?
| | Lymph Nodes | 2 | 2013 | 419 | 0.160 |
Why?
| | Exocytosis | 1 | 2019 | 89 | 0.160 |
Why?
| | Antibodies, Viral | 1 | 2022 | 520 | 0.160 |
Why?
| | Lung | 2 | 2010 | 3558 | 0.150 |
Why?
| | Melanoma, Experimental | 1 | 2018 | 89 | 0.150 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 3 | 2018 | 157 | 0.140 |
Why?
| | Cross Reactions | 1 | 2017 | 117 | 0.140 |
Why?
| | Immune Evasion | 1 | 2017 | 47 | 0.140 |
Why?
| | HIV | 1 | 2018 | 208 | 0.140 |
Why?
| | Antigens, Neoplasm | 1 | 2018 | 221 | 0.140 |
Why?
| | Models, Animal | 3 | 2019 | 344 | 0.140 |
Why?
| | Mice, Inbred MRL lpr | 4 | 2022 | 37 | 0.140 |
Why?
| | DNA-Binding Proteins | 2 | 2016 | 1314 | 0.140 |
Why?
| | Molecular Sequence Data | 2 | 2013 | 2785 | 0.140 |
Why?
| | Muramidase | 1 | 2017 | 72 | 0.140 |
Why?
| | MAP Kinase Signaling System | 1 | 2018 | 276 | 0.130 |
Why?
| | Oligodeoxyribonucleotides | 1 | 2016 | 138 | 0.130 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 2016 | 97 | 0.130 |
Why?
| | B-Cell Activation Factor Receptor | 2 | 2018 | 13 | 0.130 |
Why?
| | Microspheres | 1 | 2016 | 123 | 0.130 |
Why?
| | Excipients | 1 | 2015 | 49 | 0.130 |
Why?
| | Immunoglobulin Heavy Chains | 2 | 2013 | 72 | 0.120 |
Why?
| | Cell Adhesion | 2 | 2007 | 431 | 0.120 |
Why?
| | Ovalbumin | 1 | 2015 | 161 | 0.120 |
Why?
| | Cell Separation | 3 | 2011 | 291 | 0.120 |
Why?
| | Erythropoietin | 1 | 2015 | 72 | 0.120 |
Why?
| | Cell Proliferation | 3 | 2018 | 2186 | 0.120 |
Why?
| | Serum Albumin | 1 | 2015 | 137 | 0.120 |
Why?
| | GTP-Binding Protein alpha Subunits, G12-G13 | 1 | 2014 | 5 | 0.120 |
Why?
| | B7-2 Antigen | 1 | 2014 | 25 | 0.120 |
Why?
| | Mitochondrial Proteins | 1 | 2016 | 219 | 0.120 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2018 | 959 | 0.120 |
Why?
| | Neoplastic Processes | 1 | 2013 | 4 | 0.110 |
Why?
| | Immunologic Surveillance | 1 | 2013 | 19 | 0.110 |
Why?
| | Disease Models, Animal | 2 | 2017 | 3531 | 0.110 |
Why?
| | ras Proteins | 1 | 2014 | 138 | 0.110 |
Why?
| | Calcium | 1 | 2019 | 1104 | 0.110 |
Why?
| | Genes, Immunoglobulin Heavy Chain | 1 | 2013 | 10 | 0.110 |
Why?
| | Receptors, Cytokine | 1 | 2013 | 33 | 0.110 |
Why?
| | Ligands | 2 | 2016 | 561 | 0.100 |
Why?
| | Antibody Specificity | 1 | 2013 | 176 | 0.100 |
Why?
| | Leukocytes | 2 | 2013 | 276 | 0.100 |
Why?
| | Plasma Cells | 1 | 2012 | 56 | 0.100 |
Why?
| | Glucocorticoid-Induced TNFR-Related Protein | 1 | 2012 | 5 | 0.100 |
Why?
| | Rhadinovirus | 1 | 2012 | 16 | 0.100 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2013 | 353 | 0.100 |
Why?
| | Tumor Virus Infections | 1 | 2012 | 43 | 0.100 |
Why?
| | Transplantation, Homologous | 1 | 2013 | 377 | 0.100 |
Why?
| | Enzyme Induction | 1 | 2011 | 84 | 0.100 |
Why?
| | Autocrine Communication | 1 | 2011 | 42 | 0.100 |
Why?
| | Species Specificity | 1 | 2013 | 542 | 0.100 |
Why?
| | Interleukin Receptor Common gamma Subunit | 1 | 2011 | 15 | 0.090 |
Why?
| | Immunoglobulins | 2 | 2012 | 142 | 0.090 |
Why?
| | Gene Expression Regulation | 3 | 2018 | 2319 | 0.090 |
Why?
| | Transplantation Chimera | 1 | 2011 | 51 | 0.090 |
Why?
| | Genetic Variation | 1 | 2015 | 870 | 0.090 |
Why?
| | Herpesviridae Infections | 1 | 2012 | 138 | 0.090 |
Why?
| | Reperfusion Injury | 1 | 2013 | 255 | 0.090 |
Why?
| | Ficoll | 1 | 2010 | 5 | 0.090 |
Why?
| | Immunoglobulin Class Switching | 1 | 2010 | 15 | 0.090 |
Why?
| | Kinetics | 2 | 2012 | 1551 | 0.090 |
Why?
| | Toll-Like Receptor 3 | 1 | 2010 | 26 | 0.090 |
Why?
| | Poly I-C | 1 | 2010 | 51 | 0.090 |
Why?
| | Models, Immunological | 2 | 2012 | 92 | 0.090 |
Why?
| | Receptors, IgG | 1 | 2010 | 67 | 0.090 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2010 | 590 | 0.090 |
Why?
| | Graft Rejection | 1 | 2013 | 513 | 0.080 |
Why?
| | Antibodies, Monoclonal | 1 | 2016 | 1262 | 0.080 |
Why?
| | Immune System | 1 | 2011 | 172 | 0.080 |
Why?
| | Kidney Diseases | 1 | 2013 | 350 | 0.080 |
Why?
| | Leukocyte Count | 1 | 2010 | 293 | 0.080 |
Why?
| | Female | 12 | 2022 | 59466 | 0.080 |
Why?
| | Amino Acid Sequence | 1 | 2013 | 1982 | 0.080 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2010 | 270 | 0.080 |
Why?
| | Transcription Factors | 1 | 2016 | 1528 | 0.080 |
Why?
| | Epitopes | 1 | 2010 | 435 | 0.080 |
Why?
| | Respiratory Function Tests | 1 | 2010 | 522 | 0.080 |
Why?
| | Cell Membrane Structures | 1 | 2007 | 5 | 0.080 |
Why?
| | RGS Proteins | 1 | 2007 | 12 | 0.070 |
Why?
| | Models, Molecular | 1 | 2013 | 1369 | 0.070 |
Why?
| | Vaccines | 1 | 2013 | 375 | 0.070 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 923 | 0.070 |
Why?
| | Immunoglobulin Allotypes | 1 | 2007 | 6 | 0.070 |
Why?
| | Protein Structure, Quaternary | 1 | 2007 | 115 | 0.070 |
Why?
| | Molecular Weight | 1 | 2007 | 331 | 0.070 |
Why?
| | Male | 9 | 2022 | 55554 | 0.070 |
Why?
| | Bone Marrow | 2 | 2023 | 243 | 0.070 |
Why?
| | Phosphatidylinositol 3-Kinases | 2 | 2023 | 329 | 0.070 |
Why?
| | Bronchial Provocation Tests | 1 | 2007 | 51 | 0.070 |
Why?
| | Kidney Transplantation | 1 | 2013 | 541 | 0.070 |
Why?
| | Biomechanical Phenomena | 1 | 2010 | 668 | 0.070 |
Why?
| | Interleukin-23 | 1 | 2006 | 15 | 0.070 |
Why?
| | Cell Polarity | 1 | 2007 | 131 | 0.070 |
Why?
| | Mycoplasma pneumoniae | 1 | 2006 | 28 | 0.070 |
Why?
| | Pneumonia, Mycoplasma | 1 | 2006 | 30 | 0.070 |
Why?
| | Kidney | 1 | 2013 | 1188 | 0.070 |
Why?
| | Protein Transport | 1 | 2007 | 395 | 0.070 |
Why?
| | Interleukin-17 | 1 | 2006 | 104 | 0.070 |
Why?
| | Lung Neoplasms | 1 | 2018 | 2177 | 0.070 |
Why?
| | Gene Rearrangement, B-Lymphocyte | 1 | 2005 | 7 | 0.060 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2011 | 520 | 0.060 |
Why?
| | RNA Editing | 1 | 2005 | 20 | 0.060 |
Why?
| | Protein Structure, Tertiary | 1 | 2007 | 796 | 0.060 |
Why?
| | Lipopolysaccharides | 1 | 2008 | 821 | 0.060 |
Why?
| | Hybridomas | 3 | 2012 | 230 | 0.060 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2012 | 797 | 0.060 |
Why?
| | Particle Size | 2 | 2016 | 317 | 0.060 |
Why?
| | Phosphatidylinositol 3-Kinase | 1 | 2023 | 26 | 0.050 |
Why?
| | Enzyme Activation | 2 | 2018 | 785 | 0.050 |
Why?
| | Receptors, Cell Surface | 1 | 2004 | 355 | 0.050 |
Why?
| | Cell Line | 1 | 2007 | 2635 | 0.050 |
Why?
| | Neutrophils | 1 | 2006 | 1176 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2023 | 398 | 0.040 |
Why?
| | Cell Membrane | 1 | 2004 | 680 | 0.040 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2023 | 367 | 0.040 |
Why?
| | Age Factors | 3 | 2013 | 2894 | 0.040 |
Why?
| | CD40 Ligand | 1 | 2018 | 39 | 0.040 |
Why?
| | Antigen-Presenting Cells | 1 | 2018 | 150 | 0.040 |
Why?
| | Receptors, Complement 3d | 1 | 2019 | 130 | 0.040 |
Why?
| | Retroviridae | 1 | 2018 | 90 | 0.040 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2018 | 127 | 0.040 |
Why?
| | Transduction, Genetic | 1 | 2018 | 113 | 0.040 |
Why?
| | Transgenes | 1 | 2018 | 170 | 0.040 |
Why?
| | Genetic Vectors | 1 | 2018 | 289 | 0.030 |
Why?
| | Interleukins | 1 | 2018 | 236 | 0.030 |
Why?
| | Chickens | 1 | 2017 | 177 | 0.030 |
Why?
| | Adsorption | 1 | 2017 | 119 | 0.030 |
Why?
| | Protein Aggregates | 1 | 2017 | 65 | 0.030 |
Why?
| | Immunoglobulin lambda-Chains | 1 | 2015 | 6 | 0.030 |
Why?
| | Immunoglobulin kappa-Chains | 1 | 2015 | 18 | 0.030 |
Why?
| | Injections, Subcutaneous | 1 | 2016 | 134 | 0.030 |
Why?
| | Epoetin Alfa | 1 | 2015 | 6 | 0.030 |
Why?
| | Monocytes | 1 | 2018 | 502 | 0.030 |
Why?
| | Aluminum Hydroxide | 1 | 2015 | 12 | 0.030 |
Why?
| | Interleukin-4 | 1 | 2016 | 206 | 0.030 |
Why?
| | Antigens, CD19 | 1 | 2015 | 91 | 0.030 |
Why?
| | Syringes | 1 | 2015 | 41 | 0.030 |
Why?
| | Immunophenotyping | 1 | 2015 | 274 | 0.030 |
Why?
| | Immunoglobulin E | 1 | 2016 | 314 | 0.030 |
Why?
| | Hypodermoclysis | 1 | 2013 | 4 | 0.030 |
Why?
| | Protein Conformation | 1 | 2017 | 805 | 0.030 |
Why?
| | Injections, Intraperitoneal | 1 | 2013 | 99 | 0.030 |
Why?
| | Injections, Intravenous | 1 | 2013 | 198 | 0.030 |
Why?
| | Chemistry, Pharmaceutical | 1 | 2013 | 98 | 0.030 |
Why?
| | Clonal Selection, Antigen-Mediated | 1 | 2012 | 3 | 0.030 |
Why?
| | Lymphocyte Count | 1 | 2013 | 133 | 0.030 |
Why?
| | Lymphocyte Depletion | 1 | 2013 | 116 | 0.030 |
Why?
| | Toll-Like Receptor 7 | 1 | 2012 | 35 | 0.030 |
Why?
| | Adoptive Transfer | 1 | 2013 | 195 | 0.030 |
Why?
| | fas Receptor | 1 | 2012 | 91 | 0.030 |
Why?
| | Lupus Nephritis | 1 | 2012 | 52 | 0.020 |
Why?
| | Oxygen | 1 | 2016 | 854 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2012 | 271 | 0.020 |
Why?
| | Cell Communication | 1 | 2013 | 279 | 0.020 |
Why?
| | B-Cell Activating Factor | 1 | 2010 | 18 | 0.020 |
Why?
| | Weight Gain | 1 | 2013 | 453 | 0.020 |
Why?
| | Genes, bcl-2 | 1 | 2010 | 20 | 0.020 |
Why?
| | Immunoglobulin Light Chains | 1 | 2010 | 35 | 0.020 |
Why?
| | Autoimmune Diseases | 1 | 2012 | 382 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2011 | 778 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2010 | 740 | 0.020 |
Why?
| | Apoptosis | 1 | 2016 | 2362 | 0.020 |
Why?
| | Interleukin-23 Subunit p19 | 1 | 2006 | 5 | 0.020 |
Why?
| | Interleukin-12 Subunit p40 | 1 | 2006 | 7 | 0.020 |
Why?
| | Cell Survival | 1 | 2010 | 1020 | 0.020 |
Why?
| | Rats | 1 | 2014 | 4958 | 0.020 |
Why?
| | Binding Sites, Antibody | 1 | 2005 | 36 | 0.020 |
Why?
| | src-Family Kinases | 1 | 2005 | 88 | 0.020 |
Why?
| | Clonal Deletion | 1 | 2004 | 16 | 0.010 |
Why?
| | Alleles | 1 | 2005 | 789 | 0.010 |
Why?
| | Cell Division | 1 | 2004 | 758 | 0.010 |
Why?
| | Phosphorylation | 1 | 2005 | 1569 | 0.010 |
Why?
|
|
Torres's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|